Paul Choi Stock Analyst Profile - Goldman Sachs Research Coverage - Stocknear

Paul Choi

Stock Analyst at Goldman Sachs

(3.62)
# 2582
Out of 5,506 analysts
145
Total ratings
Success rate
Average return

43 Stocks

Name Action PT Current % Upside Ratings Updated
EWTX Edgewise Therapeutic...
Initiates Coverage On: Neutral
20
15.65 27.8% 1 Sep 25, 2025
EXEL Exelixis
Initiates Coverage On: Buy
47
40.09 17.24% 1 Sep 17, 2025
AMRN Amarin Corp
Maintains: Sell
7 12
18.84 -36.31% 8 Jun 25, 2025
URGN UroGen Pharma
Maintains: Neutral
16 3
17.4 -82.76% 4 May 22, 2025
GOSS Gossamer Bio
Maintains: Strong Buy
7 8
2.57 211.28% 6 May 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
10 5
12.21 -59.05% 10 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
12 8
9.61 -16.75% 3 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
60 52
39.61 31.28% 2 Apr 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
28 21
5.73 266.49% 8 Apr 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
14 12
10.43 15.05% 3 Apr 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
4 3
3.3 -9.09% 9 Apr 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
12 10
10.1 -0.99% 4 Apr 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
200 225
204.05 10.27% 4 Feb 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
143
53.83 165.65% 1 Dec 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
32 42
65.37 -35.75% 7 Dec 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
85 60
56.97 5.32% 2 Aug 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
17 19
16.09 18.09% 6 Aug 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
22 32
38.49 -16.86% 1 Jul 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
29 50
52.86 -5.41% 6 Jul 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
21 19
4.64 309.48% 3 Jun 29, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
400 50
11.73 326.26% 7 Jun 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
29 26
n/a n/a 2 Apr 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
29 4
n/a n/a 1 Oct 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
43 25
1.44 1636.11% 3 May 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
450 100
n/a n/a 3 May 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
10 4
n/a n/a 4 May 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
25 4
n/a n/a 1 Apr 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
151 170
15.81 975.27% 2 Oct 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
225 125
n/a n/a 2 Sep 22, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
9 8
5.13 55.95% 4 Aug 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Neutral
132
n/a n/a 3 Mar 22, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
33
n/a n/a 1 Mar 22, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
112
n/a n/a 1 Mar 22, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
30
n/a n/a 1 Jan 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
28
n/a n/a 1 Aug 11, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
48 49
n/a n/a 4 Jul 15, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
91 103
n/a n/a 2 Jul 1, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
135
137.03 -1.48% 1 Jun 29, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
240
n/a n/a 2 Jun 8, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
5 22
n/a n/a 3 Apr 24, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
270 300
60.55 395.46% 2 Mar 30, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
58 40
n/a n/a 3 Oct 31, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
60 56
n/a n/a 3 Aug 6, 2018